
Sign up to save your podcasts
Or
Will new clinical trials for Covid-19 give remdesivir a second chance?Ben Valsler introduces the broad-spectrum antiviral that didn't quite make it as the Ebola drug it was originally planned to be.
4.7
180180 ratings
Will new clinical trials for Covid-19 give remdesivir a second chance?Ben Valsler introduces the broad-spectrum antiviral that didn't quite make it as the Ebola drug it was originally planned to be.
43,944 Listeners
90,431 Listeners
8,513 Listeners
43,406 Listeners
112,857 Listeners
9,995 Listeners
135 Listeners
3,274 Listeners
15 Listeners
2,194 Listeners
2 Listeners